Expert panel agrees on early detection and ARPI/ADT role for high-risk prostate cancer BCR
Experts agree on some approaches for high-risk prostate cancer recurrence but disagree on timing
An expert opinion review summarized panel discussions on managing high-risk biochemical recurrence in prostate cancer. The panel reached agr…
Experts agree on early detection and medication use for high-risk prostate cancer recurrence but disagree on the best timing for starting tr…
PSMA PET parameters predict biochemical recurrence in high-risk prostate cancer after neoadjuvant hormonal therapy
PET scan measures may help predict prostate cancer recurrence after hormone therapy
A phase II RCT of 89 high-risk primary prostate cancer patients found that posttreatment PSMA-expressing volume and pretreatment metastatic …
A specialized PET scan after hormone therapy can predict which high-risk prostate cancer patients face a higher risk of their disease return…